Published in Curr Opin Chem Biol on June 01, 2008
Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod (2012) 13.27
Natural products: a continuing source of novel drug leads. Biochim Biophys Acta (2013) 4.12
Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther (2013) 2.64
An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors. J Am Chem Soc (2010) 2.30
Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles. Proc Natl Acad Sci U S A (2010) 2.01
Expanding the range of 'druggable' targets with natural product-based libraries: an academic perspective. Curr Opin Chem Biol (2010) 1.91
Modern natural products drug discovery and its relevance to biodiversity conservation. J Nat Prod (2010) 1.90
Novel chemical space exploration via natural products. J Med Chem (2009) 1.27
How proteins bind macrocycles. Nat Chem Biol (2014) 1.24
Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin. J Am Chem Soc (2009) 1.24
Quantifying structure and performance diversity for sets of small molecules comprising small-molecule screening collections. Proc Natl Acad Sci U S A (2011) 1.20
Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors. Curr Pharm Des (2010) 1.20
Highly enantioselective synthesis and cellular evaluation of spirooxindoles inspired by natural products. Nat Chem (2010) 1.19
Immunosuppressant discovery from Tripterygium wilfordii Hook f: the novel triptolide analog (5R)-5-hydroxytriptolide (LLDT-8). Acta Pharmacol Sin (2012) 1.17
A diversity-oriented synthesis approach to macrocycles via oxidative ring expansion. Nat Chem Biol (2012) 1.15
A call for using natural compounds in the development of new antimalarial treatments - an introduction. Malar J (2011) 1.14
Cancer wars: natural products strike back. Front Chem (2014) 1.11
Distinct biological network properties between the targets of natural products and disease genes. J Am Chem Soc (2010) 1.08
Metabolic reprogramming of periwinkle plant culture. Nat Chem Biol (2009) 1.04
Role of natural product diversity in chemical biology. Curr Opin Chem Biol (2011) 1.01
Yeast artificial chromosomes employed for random assembly of biosynthetic pathways and production of diverse compounds in Saccharomyces cerevisiae. Microb Cell Fact (2009) 1.01
Solid-phase synthesis and chemical space analysis of a 190-membered alkaloid/terpenoid-like library. Proc Natl Acad Sci U S A (2011) 0.99
A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease. PLoS One (2011) 0.98
Total synthesis and biological evaluation of tyroscherin. Org Lett (2010) 0.92
Site-specific recombination strategies for engineering actinomycete genomes. Appl Environ Microbiol (2012) 0.92
Probing chemical space with alkaloid-inspired libraries. Nat Chem (2014) 0.91
The structural biology of patellamide biosynthesis. Curr Opin Struct Biol (2014) 0.91
Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology. Mol Inform (2014) 0.90
Small molecule inhibition of the TNF family cytokine CD40 ligand through a subunit fracture mechanism. ACS Chem Biol (2011) 0.90
Drug discovery from plant sources: An integrated approach. Ayu (2012) 0.89
Bioassays to monitor Taspase1 function for the identification of pharmacogenetic inhibitors. PLoS One (2011) 0.89
Accessing Stereochemically Rich Sultams via Microwave-Assisted, Continuous Flow Organic Synthesis (MACOS) Scale-out. J Flow Chem (2011) 0.87
Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives. Bioorg Med Chem (2012) 0.87
Back to the future with phenotypic screening. ACS Chem Neurosci (2014) 0.86
Chemoinformatic analysis of GRAS (Generally Recognized as Safe) flavor chemicals and natural products. PLoS One (2012) 0.86
In silico investigation of potential SRC kinase ligands from traditional Chinese medicine. PLoS One (2012) 0.86
Drug design of cyclin-dependent kinase 2 inhibitor for melanoma from traditional Chinese medicine. Biomed Res Int (2014) 0.85
Radical [3 + 2]-annulation of divinylcyclopropanes: rapid synthesis of complex meloscine analogs. Org Lett (2013) 0.84
Advances in the research and development of natural health products as main stream cancer therapeutics. Evid Based Complement Alternat Med (2015) 0.84
Creation and manipulation of common functional groups en route to a skeletally diverse chemical library. Proc Natl Acad Sci U S A (2011) 0.84
DrugMint: a webserver for predicting and designing of drug-like molecules. Biol Direct (2013) 0.82
Structural diversity of biologically interesting datasets: a scaffold analysis approach. J Cheminform (2011) 0.82
Anti-malarial activity of a polyherbal product (Nefang) during early and established Plasmodium infection in rodent models. Malar J (2014) 0.81
Screening of the anticonvulsant activity of some plants from Fabaceae family in experimental seizure models in mice. Daru (2011) 0.81
A chemogenomic analysis of ionization constants--implications for drug discovery. ChemMedChem (2013) 0.81
High-throughput screen of natural product libraries for hsp90 inhibitors. Biology (Basel) (2014) 0.81
Phospholipase A2 isolated from the venom of Crotalus durissus terrificus inactivates dengue virus and other enveloped viruses by disrupting the viral envelope. PLoS One (2014) 0.80
Exploration of the antiplatelet activity profile of betulinic acid on human platelets. J Agric Food Chem (2012) 0.80
Merging allosteric and active site binding motifs: de novo generation of target selectivity and potency via natural-product-derived fragments. ChemMedChem (2014) 0.80
Terpenyl-purines from the sea. Mar Drugs (2009) 0.80
Treatment of rheumatoid arthritis with traditional chinese medicine. Biomed Res Int (2014) 0.79
Discovery of dihydrochalcone as potential lead for Alzheimer's disease: in silico and in vitro study. PLoS One (2013) 0.78
Synthetic strategies to terpene quinones/hydroquinones. Mar Drugs (2012) 0.77
New Frontiers in Druggability. J Med Chem (2015) 0.77
Recent advances and applications of experimental technologies in marine natural product research. Mar Drugs (2015) 0.77
Assembly of four diverse heterocyclic libraries enabled by Prins cyclization, Au-catalyzed enyne cycloisomerization, and automated amide synthesis. J Org Chem (2012) 0.76
Catenarin Prevents Type 1 Diabetes in Nonobese Diabetic Mice via Inhibition of Leukocyte Migration Involving the MEK6/p38 and MEK7/JNK Pathways. Evid Based Complement Alternat Med (2012) 0.76
Cheminformatic comparison of approved drugs from natural product versus synthetic origins. Bioorg Med Chem Lett (2015) 0.76
Capturing nature's diversity. PLoS One (2015) 0.76
Dandelion root extract affects colorectal cancer proliferation and survival through the activation of multiple death signalling pathways. Oncotarget (2016) 0.75
Parallel and four-step synthesis of natural-product-inspired scaffolds through modular assembly and divergent cyclization. Beilstein J Org Chem (2012) 0.75
Tropical protozoan diseases: natural product drug discovery and development. Evid Based Complement Alternat Med (2013) 0.75
Concise Synthesis of Spergualin-Inspired Molecules With Broad-Spectrum Antibiotic Activity. Medchemcomm (2015) 0.75
Anticonvulsant effect of Cicer arietinum seed in animal models of epilepsy: introduction of an active molecule with novel chemical structure. Iran Biomed J (2015) 0.75
Stereodivergent approach to the avermectins based on "super silyl" directed aldol reactions. Org Lett (2014) 0.75
Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents. Sci Rep (2016) 0.75
Evaluations of the Antimicrobial Activities and Chemical Compositions of Body Fat from the Amphibians Leptodactylus macrosternum Miranda-Ribeiro (1926) and Leptodactylus vastus Adolf Lutz (1930) in Northeastern Brazil. Evid Based Complement Alternat Med (2013) 0.75
Allocyclinones, hyperchlorinated angucyclinones from Actinoallomurus. J Antibiot (Tokyo) (2016) 0.75
Drug-likeness of Phytic Acid and Its Analogues. Open Microbiol J (2015) 0.75
Biodistribution of arctigenin-loaded nanoparticles designed for multimodal imaging. J Nanobiotechnology (2017) 0.75
Chimeric Leader Peptides for the Generation of Non-Natural Hybrid RiPP Products. ACS Cent Sci (2017) 0.75
Investigating the effect of gallium curcumin and gallium diacetylcurcumin complexes on the structure, function and oxidative stability of the peroxidase enzyme and their anticancer and antibacterial activities. J Biol Inorg Chem (2015) 0.75
NuBBEDB: an updated database to uncover chemical and biological information from Brazilian biodiversity. Sci Rep (2017) 0.75
Chemoselective fluorination and chemoinformatic analysis of griseofulvin: Natural vs fluorinated fungal metabolites. Bioorg Med Chem (2017) 0.75
Synthesis and pharmacological evaluation of carvacrol propionate. Inflammation (2014) 0.75
Ligand binding to anti-cancer target CD44 investigated by molecular simulations. J Mol Model (2016) 0.75